Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Bio Medica Corporation
ABMC Complies with NASDAQ Marketplace Rule 4350(b)(1)(B)
April 25th, 2008
American Bio Medica Corporation (NASDAQ:ABMC) in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification, disclosed that its financial statements for the fiscal year ended December 31, 2007 filed on March 28, 2008 contains a going concern qualification from its independent registered public accounting firm, UHY LLP. This announcement does not represent any change or amendment to the Company's 2007 financial statements or to its Annual Report on Form 10-KSB. For more information on ABMC or its drug testing products, please visit...
Source: Health Business Week (2008-04-25)
|
